β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients.

Ya-Wen LoAlan Yueh-Luen LeeYi-Ching LiuHui-Hsin KoHsin-Hui PengHsiang-Chieh LeePei-Yao PanChun-Pin ChiangShih-Jung Cheng

Published in: Oral diseases (2021)

Preoperative administration of β-glucan can augment anti-tumor immunity and increase RFS rate via subversion of suppressive function of MDSC in OSCC patients.

Keyphrases

end stage renal disease
newly diagnosed
induced apoptosis
chronic kidney disease
peritoneal dialysis
prognostic factors
patients undergoing
cell cycle arrest
cell proliferation
patient reported outcomes
endoplasmic reticulum stress